Emyria

🍄 Psychedelics· 📍 Perth, Australia

Overview

Australian clinical-stage biopharmaceutical company developing MDMA, psilocybin, and cannabis-derived therapeutics for mental health conditions with a data-driven clinical trial platform. They operate licensed clinics to generate real-world evidence for regulatory submissions.

More in Psychedelics

Algernon Pharmaceuticals

Vancouver, Canada

Apex Labs

Calgary, Canada

atai Life Sciences

Berlin, Germany

Awakn Europe

Bristol, United Kingdom

Awakn Life Sciences

Bristol, UK

Beckley Foundation

Oxford, United Kingdom

Latest industry news

Precision Neuroscience Raises $250M to Accelerate Brain-Computer Interface Development

2026-11-01 · Funding

Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena

2026-10-31 · Industry

Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone

2026-10-30 · Product

Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One

2026-10-29 · Research

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →